Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuation Rates of DMPA-SC vs DMPA-IM for Post-abortion Contraception
NCT05505435Phase 4Completed
- Sponsor
- Northwestern University
- Start
- Aug 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of medroxyprogesterone acetate in contraception (2 arms), sponsored by Northwestern University. Primary endpoint: DMPA Continuation Rate at 6 months. Started Aug 2022; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
contraception
Beyond the preview
Go deeper on NCT05505435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05505435.